Ekso Bionics (NASDAQ: EKSO) reported Q2 EPS of ($1.24), $1.16 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $2.06 million versus the consensus estimate of $5.51 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.